Mounjaro KwikPen 10 mg – Injectable solution for diabetes and weight loss

Introducing the Mounjaro KwikPen 10 mg

Le Mounjaro KwikPen 10 mg is a pre-filled pen containing tirzepatide injectable solution, an innovative treatment indicated for type 2 diabetes and weight loss. Each pen contains 2,4 ml of solution, equivalent to four 0,6 ml doses, ready to use. This medication acts on GLP-1 and GIP receptors, promoting blood sugar regulation and a sustained reduction in appetite.

The price of Mounjaro 10 mg in France is approximately €395, depending on the pharmacy. In Belgium, the price of Mounjaro 10 mg may vary slightly depending on the licensed pharmacy. This product is not covered by French national health insurance (Sécurité sociale), but it is available with a prescription from a pharmacy.

Why choose Mounjaro 10 mg Pen

• Clinically proven efficacy for type 2 diabetes and weight loss.
• A single weekly injection for convenient use.
• Secure pre-filled pen, easy to handle, without complex preparation.
• Store in a refrigerator (2°C to 8°C), with a stability of 30 days outside of refrigeration.
• Designed for overweight or obese adults (BMI ≥ 27).

Administration mode

Inject the product once a week into the thigh, abdomen, or arm, alternating injection sites. The pen should not be frozen. Discard it after 30 days of use. Consult your doctor before changing the dose.

Precautions and recommendations

• Do not use during pregnancy or breastfeeding.
• Keep out of children’s reach.
• Always follow medical instructions and report any side effects (nausea, diarrhea, fatigue).
• Avoid purchasing from unauthorized websites.

Key points to remember

FAQ

Is Mounjaro 10 mg reimbursed in France?
No, mounjaro It is not yet reimbursed. The price depends on the pharmacy.

Can it be used for weight loss?
Yes, it is prescribed under medical supervision for weight control in adults.

How long does a pen last?
Each pen provides 4 weekly doses, or 1 month of treatment